Independence Trust’s Novartis NVS Stock Holding History

Independence Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$455K	Hold	6,048	–	–	0.5%	34
2017 Q3	$465K	Hold	6,048	–	–	0.53%	35
2017 Q2	$452K	Hold	6,048	–	–	0.54%	35
2017 Q1	$402K	Hold	6,048	–	–	0.52%	37
2016 Q4	$395K	Buy	+6,048	New	+$392K	0.54%	35
2015 Q4	–	Sell	-3,050	Closed	-$251K	–	92
2015 Q3	$251K	Sell	3,050 -3,833	-56%	-$341K	0.26%	79
2015 Q2	$607K	Sell	6,883 -3,189	-32%	-$293K	0.41%	46
2015 Q1	$890K	Hold	10,072	–	–	0.56%	37
2014 Q4	$836K	Buy	10,072 +3,768	+60%	+$312K	0.51%	41
2014 Q3	$532K	Buy	6,304 +21	+0.3%	+$1.7K	0.35%	51
2014 Q2	$510K	Sell	6,283 -446	-7%	-$35.1K	0.33%	55
2014 Q1	$513K	Buy	6,729 +920	+16%	+$67K	0.35%	48
2013 Q4	$418K	Sell	5,809 -95	-2%	-$6.6K	0.29%	58
2013 Q3	$406K	Sell	5,904 -697	-11%	-$46.1K	0.3%	56
2013 Q2	$418K	Buy	+6,601	New	+$429K	0.3%	54

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Independence Trust's NVS Position: Q4 2017 in Review

Independence Trust held its Novartis (NVS) position steady in Q4 2017 at 6,048 shares worth $455K. The position accounts for 0.5% of the portfolio, ranked #34.

Independence Trust first reported a position in NVS in Q2 2013 and has held it in 15 quarters since. The position peaked at $890K in Q1 2015. 1,007 funds tracked by Wall St. Rank hold NVS as of Q4 2017.

Independence Trust held 6,048 shares of Novartis worth $455K as of Q4 2017.
Independence Trust left its Novartis share count unchanged in Q4 2017.
Novartis made up 0.5% of Independence Trust's portfolio in Q4 2017, its #34 holding.
Independence Trust first reported a position in Novartis in Q2 2013 and has held it in 15 quarters since.
Independence Trust's Novartis position peaked at $890K in Q1 2015.
1,007 funds tracked by Wall St. Rank held Novartis as of Q4 2017.

Based on Independence Trust's 13F filing for Q4 2017, filed 8 Feb 2018.